Pre-Approval Product Awareness

Compliant, Creative Activities and KOL Interaction
Purchase Option Price
  • Price: $379.00
  • Price: $379.00

Product Description:

AUDIOCONFERENCE ON TAPE OR CD

From the company that offers customized compliance training for Medical Science Liaison Teams

presented on OCTOBER 10, 2006

“The cost of producing a successful drug could top $2 billion by 2010”

- Steven Paul, Executive Vice President, Eli Lilly, Drug Discovery Technology conference, Boston, August 2006

So how do you create effective awareness when the legal boundaries aren't clear in the pre-market phase? With murky guidelines, managing KOLs and your pre-market educational activities is one of your biggest daily headaches and compliance worries. Trusted for delivering high-level advice, we've brought back Mark DuVal, former 3M Pharmaceuticals general counsel, to provide compliance commentary and help you push the envelope--within the rules--as you try to manage your pre-approval activities. In a back and forth style, Dr. Jeffrey Spears, PharmD, will present the scenarios and creative awareness strategies while Mark DuVal addresses the legal considerations.

So how do you create effective awareness when the legal boundaries aren't clear in the pre-market phase? With murky guidelines, managing KOLs and your pre-market educational activities are some of your biggest daily headaches and compliance worries. Trusted for delivering high-level advice, we've brought back Mark DuVal, former 3M Pharmaceuticals general counsel, to provide compliance commentary and help you push the envelope--within the rules--as you try to manage your pre-approval activities. In a back and forth style, Dr. Jeffrey Spears, PharmD, presents the scenarios and creative awareness strategies while Mark DuVal addresses the legal considerations.

Tell a colleague about
this product

ORDER CLASS: U_10-10-2006
SOURCE CODE: EHCM

Related Products